elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37015742-64FCF19A-3685-4931-8C31-C826D8810F93
Q37015742-64FCF19A-3685-4931-8C31-C826D8810F93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37015742-64FCF19A-3685-4931-8C31-C826D8810F93
Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells.
P2860
Q37015742-64FCF19A-3685-4931-8C31-C826D8810F93
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37015742-64FCF19A-3685-4931-8C31-C826D8810F93
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d5f2761a8459dfc70cf2bce602c55592edcaaac
P2860
Carfilzomib: a second-generation proteasome inhibitor for the treatment of relapsed and refractory multiple myeloma.